Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation.
CONCLUSIONS: Depending on P53 mutation status, HPV infection can contribute to a higher tumor response and better prognosis of ESCC treated with chemoradiation therapy.
PMID: 28647401 [PubMed - as supplied by publisher]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Zhang D, Zhang W, Liu W, Mao Y, Fu Z, Liu J, Huang W, Zhang Z, An D, Li B Tags: Radiother Oncol Source Type: research
More News: Cancer & Oncology | Carcinoma | Esophagus Cancer | Genetics | Genital Warts | Human Papillomavirus (HPV) | Radiology | Skin Cancer | Squamous Cell Carcinoma | Study